K

Keros Therapeutics

103 employees

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$56M

from 12 investors over 12 rounds

K

Keros Therapeutics raised $56M on March 4, 2020

Investors: Pontifax Venture Capital, Partners HealthCare, Venrock, Medison Pharma LTD., Foresite Capital and OrbiMed Advisors

K

Keros Therapeutics raised $23M on January 8, 2019

Investors: Partners HealthCare, Pontifax Venture Capital, Quark Venture and Medison Pharma LTD.

K

Keros Therapeutics raised $11M on November 9, 2017

Investors: Pontifax Venture Capital and Partners HealthCare

FAQ